Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers

Clinical trial NCT05192512 · UNKNOWN

Trial details

NCT number: NCT05192512
Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2022-01-24
Primary completion: 2024-01-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.